Red Clover and Arterial Stiffness

Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women.

 

Article Summary:

This is a review on the study that addresses the vascular effects of isolated red clover isoflavone. A randomized, double-blind trial was designed. A total of 80 healthy participants, 46 were men, and 34 were women, 45 to 75 years of age. All participants were given isoflavones enriched in either biochanin or formononetin crossed over randomly with placebo in two 6-week periods. The end points were measured at baseline and after each intervention which included large artery stiffness, endothelial function in conduit arteries, 24-hour ambulatory blood pressure, and total peripheral resistance. The study showed that the isoflavone intervention significantly reduced arterial stiffness with improved systemic arterial compliance, led to a reduction in total peripheral resistance and a corresponding reduction in central pulse wave velocity compared with placebo. There was no effect found on blood pressure or flow-mediated vasodilation. The study concluded

that red clover isoflavones enriched in formononetin reduced arterial stiffness and total vascular resistance in normotensive men and postmenopausal women but with no effect on blood pressure.

Authors:

Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel PJ.

Insititution:

Vascular Research Group, Department of Medicine, Monash University, Clayton, Australia

Country of Publication:

Australia

Source:

Arterioscler Thromb Vasc Biol. 23(6):1066-71, 2003 June. NIH

 

Return to the "Menopause Articles page. "

Copyright © 2010-2020 Seacra Enterprises, Inc. - All Rights Reserved.
Privacy Policy - Terms of Use - Site Map - Links and Resources